Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advancements in combining targeted therapy and immunotherapy for colorectal cancer
Manisha Singh, Van K. Morris, Irfan Bandey, et al.
Trends in cancer (2024) Vol. 10, Iss. 7, pp. 598-609
Closed Access | Times Cited: 21

Showing 21 citing articles:

Tailoring traditional Chinese medicine in cancer therapy
Shuiquan Li, Xi Chen, Hui Shi, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
New insight in immunotherapy and combine therapy in colorectal cancer
Kai Ji, Hang Jia, Zixuan Liu, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access | Times Cited: 1
Colorectal Cancer Spectrum: From Subtypes and Epidemiology to Oncotherapies
Nidhi Agrawal, Sanjay Kumar Lanjhiyana, Meenakshi Jaiswal, et al.
Gastroenterology & Endoscopy (2025)
Open Access | Times Cited: 1
Identification of Immune Infiltration-Associated CC Motif Chemokine Ligands as Biomarkers and Targets for Colorectal Cancer Prevention and Immunotherapy
Minghao Liu, Teng Wang, Mingyang Li
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 625-625
Open Access
Neoadjuvant Treatment in Rectal Cancer
Srinath Bhradwaj R., Aditya Sarin, Shyam Aggarwal, et al.
South Asian Journal of Cancer (2025)
Open Access
Immunogenic Cuproptosis in Cancer Immunotherapy via an In Situ Cuproptosis-Inducing System
Jiehan Li, Ge Zhang, Kai Zhao, et al.
Biomaterials (2025) Vol. 319, pp. 123201-123201
Closed Access
Distinct Immunophenotypic Profiles and Neutrophil Heterogeneity in Colorectal Cancer
Minghua Bai, Yuzhao Jin, Zihao Jin, et al.
Cancer Letters (2025) Vol. 616, pp. 217570-217570
Closed Access
Combination therapy with immune checkpoint inhibitors in colorectal cancer: Challenges, resistance mechanisms, and the role of microbiota
Ali Rahimi, Zeinab Baghernejadan, Ali Hazrati, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 118014-118014
Closed Access
Tumor-microenvironment-activated bimetallic oxide nanoplatform for second near-infrared region fluorescence-guided colon tumor surgery and multimodal synergistic therapy
Christos Masouros, Ziqian Zhang, Yunfei Ying, et al.
Journal of Colloid and Interface Science (2025), pp. 137529-137529
Closed Access
Metal-based nanomedicine systems for the diagnosis and treatment of colorectal cancer: Current advances and future perspectives
Jie Gou, Lu Chen, Tianyu Liu, et al.
Materials Today Chemistry (2025) Vol. 45, pp. 102702-102702
Closed Access
Identification and validation of CDK1 as a promising therapeutic target for Eriocitrin in colorectal cancer: a combined bioinformatics and experimental approach
Jiemiao Shen, Xing Gong, Haili Ren, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Recruitment of USP10 by GCS1 to deubiquitinate GRP78 promotes the progression of colorectal cancer via alleviating endoplasmic reticulum stress
Chen Yang, Hengyang Shen, Zhenling Wang, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 3
Unveiling the pathological functions of SOCS in colorectal cancer: current concepts and future perspectives
Yuhan Wang, Sha Wu, ZhiHui Song, et al.
Pathology - Research and Practice (2024) Vol. 262, pp. 155564-155564
Closed Access | Times Cited: 2
Natural compounds modulate the mechanism of action of tumour-associated macrophages against colorectal cancer: a review
Weichen Yuan, Jiexiang Zhang, Haibin Chen, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 11
Open Access | Times Cited: 1
The efficacy of targeted therapy and/or immunotherapy with or without chemotherapy in patients with Colorectal Cancer: A Network Meta-Analysis
Haoyan Guo, Ling Miao, C. Yu
European Journal of Pharmacology (2024), pp. 177219-177219
Closed Access | Times Cited: 1
A comprehensive pan-cancer analysis revealing the role of ITPRIPL1 as a prognostic and immunological biomarker
Wenyuan Duan, Wenhao Tian, Zhongyi Li, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access
Type I Diabetes Mellitus impairs cytotoxic immunity through CEACAM5 upregulation in colorectal cancer
Yingying Li, Feng Xingyong, Zhao Deying, et al.
Journal of Molecular Histology (2024) Vol. 55, Iss. 6, pp. 1285-1293
Closed Access
CYP19A1 regulates chemoresistance in colorectal cancer through modulation of estrogen biosynthesis and mitochondrial function
Yang Wang, Qiang Ji, N. Cao, et al.
Cancer & Metabolism (2024) Vol. 12, Iss. 1
Open Access
Tumor microenvironment activatable hollowed cobalt based nanoreactor for synergistic ablating colon malignancy via photothermal amplified ROS Storm
Z. Wu, Yuanyuan Peng, Wei Wang, et al.
Applied Materials Today (2024) Vol. 41, pp. 102487-102487
Closed Access
Palmatine attenuates MYH9 mediated nuclear localization of AURKA to induce G2/M phase arrest in colorectal cancer cells
Wanyu Tang, Jingwei Li, Yuan Zhou, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113615-113615
Closed Access
CBLN2 overexpression inhibits colorectal cancer progression and improves immunotherapy responses
Zeyu Wang, Hui Pan, Jun Zhou, et al.
International Immunopharmacology (2024) Vol. 144, pp. 113566-113566
Closed Access
How the Versatile Self‐Assembly in Drug Delivery System to Afford Multimodal Cancer Therapy?
Yuqi Cao, Xiaomin Zhao, Yuhang Miao, et al.
Advanced Healthcare Materials (2024)
Closed Access
Ursolic acid in colorectal cancer: mechanisms, current status, challenges, and future research directions
Hongjian Zhang, Xiaoyu Zhang, Xijun Ma, et al.
Pharmacological Reports (2024)
Closed Access
Discovery of novel xanthohumol C derivatives regulating XRCC2 transcription and expression for the treatment of colorectal cancer
Qianqian Zhu, Mengying Wang, Yan Wang, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 118, pp. 118048-118048
Closed Access
Page 1

Scroll to top